BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1616424)

  • 1. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions.
    Pinto MM; Bernstein LH; Rudolph RA; Brogan DA; Rosman M
    Arch Pathol Lab Med; 1992 Jun; 116(6):626-31. PubMed ID: 1616424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen in effusions. A diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo EM
    Acta Cytol; 1987; 31(2):113-8. PubMed ID: 3548190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology.
    Whiteside TL; Dekker A
    Acta Cytol; 1979; 23(6):443-8. PubMed ID: 295160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
    Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W
    Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F; Fukuoka M; Takada M; Tamai S; Sakai N; Negoro S; Okunaka N; Sone S; Tsubura E
    Jpn J Clin Oncol; 1984 Sep; 14(3):321-7. PubMed ID: 6090732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
    Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches in the diagnostic procedure of malignant pleural effusions.
    Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
    Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the determination of CA 15-3 in the diagnosis of malignant pleural effusion].
    Romero S; Hernández L; Salar A; García-Sevila R; Espasa MA; Martín-Serrano C
    Rev Clin Esp; 1992 Apr; 190(7):339-43. PubMed ID: 1620918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
    Gulyás M; Elek G; Molnár M; Szollár L
    Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
    An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
    Niwa Y; Shimokata K
    Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].
    Yang Z; Xie C
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
    Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F
    Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoradiometric assay of CA 125 in effusions. Comparison with carcinoembryonic antigen.
    Pinto MM; Bernstein LH; Brogan DA; Criscuolo E
    Cancer; 1987 Jan; 59(2):218-22. PubMed ID: 3467816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of pleural effusions].
    Ogino M; Koike K; Satoh K; Arai K
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1770-4. PubMed ID: 6476843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion.
    Sthaneshwar P; Yap SF; Jayaram G
    Malays J Pathol; 2002 Jun; 24(1):53-8. PubMed ID: 16329556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ; De Miguel J; García Díaz JD; Díez M
    Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.